Nantahala Capital Management LLC 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN | Nantahala Capital Management LLC | 2,834,336 9.990% | 36,748 (+1.31%) | Filing |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Nantahala Capital Management LLC | 1,952,368 5.100% | 1,952,368 (New Position) | Filing |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Nantahala Capital Management LLC | 2,797,588 9.900% | 2,797,588 (New Position) | Filing |